ABSTRACT Introduction Familial Mediterranean Fever (FMF) is the most common
autoinflammatory disease that has mainly been treated with colchicine since 1972. A …

Familial Mediterranean fever (FMF) is inherited autosomal recessively; however,
heterozygotes may express FMF phenotype. We aimed to define the characteristics of FMF …

Abstract Familial Mediterranean Fever, a monogenic autoinflammatory disease secondary to
MEFV gene mutations in the chromosome 16p13, is characterized by recurrent self-limiting …

Familial Mediterranean fever (FMF) is the most common autoinflammatory hereditary
disease characterized by self-limited attacks of fever and serositis. Although colchicine is the …

OBJECTIVE: To evaluate the efficacy and safety of weekly intravenous (IV) colchicine, in
addition to oral colchicine therapy, in a subset of patients with familial Mediterranean fever …

Familial Mediterranean fever (FMF) is the most common monogenic periodic fever syndrome
and characterized by recurrent episodes of fever, serositis, arthritis, dermal manifestations …

Objective Approximately 10%–20% of patients with familial Mediterranean fever (FMF) show
an inadequate response to colchicine. In our cohort study, patients with FMF with or without …

Familial Mediterranean fever (FMF) is the most common monogenic autoinflammatory
disease manifesting phenotypic heterogeneity. It is a clinically diagnosed disease supported …

ABSTRACT Objective. About 10-20% of familial M edite rranean fever (FMF) patients a re
resistant to regular colchicine t reatment and have painful re cu rre nt attacks due to …

Objective. The gene causing familial Mediterranean fever (FMF)—an autosomal recessive
disease characterized by recurrent short episodes of fever associated most commonly with …